Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a ful l
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type“ NCT03550378” into the
“Other Terms” search box, and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click“ Home and
Search”, then type “2018-000019-26” in the search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5670C00013” into the search box, and click “Find a Study”.
Full study title: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled
Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MEDI0382 in
Subjects with Type 2 Diabetes Mellitus and Renal Impairment
National Clinical Trials number: NCT03550378
AstraZeneca Protocol Number: D5670C00013
MedImmune Ltd, an AstraZeneca company, sponsored this study and has its
headquarters in Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240 9479.
Thank you!
Clinical trial participants belong to a large community of people who take part i n
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP)
is a non-profit organization focused on educating and informing the public about
clinical research participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100
Boston, MA 02109
1-877-MED-HERO
8
Version 2.0 2020_02_06